1. Home
  2. SVRA vs SCWX Comparison

SVRA vs SCWX Comparison

Compare SVRA & SCWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • SCWX
  • Stock Information
  • Founded
  • SVRA N/A
  • SCWX 1999
  • Country
  • SVRA United States
  • SCWX United States
  • Employees
  • SVRA N/A
  • SCWX N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • SCWX Computer Software: Prepackaged Software
  • Sector
  • SVRA Health Care
  • SCWX Technology
  • Exchange
  • SVRA Nasdaq
  • SCWX Nasdaq
  • Market Cap
  • SVRA 739.1M
  • SCWX 655.9M
  • IPO Year
  • SVRA N/A
  • SCWX 2016
  • Fundamental
  • Price
  • SVRA $3.82
  • SCWX $8.22
  • Analyst Decision
  • SVRA Strong Buy
  • SCWX Sell
  • Analyst Count
  • SVRA 5
  • SCWX 2
  • Target Price
  • SVRA $12.00
  • SCWX $7.00
  • AVG Volume (30 Days)
  • SVRA 1.3M
  • SCWX 31.6K
  • Earning Date
  • SVRA 11-07-2024
  • SCWX 09-05-2024
  • Dividend Yield
  • SVRA N/A
  • SCWX N/A
  • EPS Growth
  • SVRA N/A
  • SCWX N/A
  • EPS
  • SVRA N/A
  • SCWX N/A
  • Revenue
  • SVRA N/A
  • SCWX $346,352,000.00
  • Revenue This Year
  • SVRA N/A
  • SCWX N/A
  • Revenue Next Year
  • SVRA N/A
  • SCWX $3.91
  • P/E Ratio
  • SVRA N/A
  • SCWX N/A
  • Revenue Growth
  • SVRA N/A
  • SCWX N/A
  • 52 Week Low
  • SVRA $3.12
  • SCWX $5.40
  • 52 Week High
  • SVRA $5.70
  • SCWX $9.76
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 35.17
  • SCWX 54.19
  • Support Level
  • SVRA $3.77
  • SCWX $7.55
  • Resistance Level
  • SVRA $4.33
  • SCWX $8.85
  • Average True Range (ATR)
  • SVRA 0.22
  • SCWX 0.48
  • MACD
  • SVRA -0.07
  • SCWX 0.02
  • Stochastic Oscillator
  • SVRA 9.28
  • SCWX 64.61

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About SCWX SecureWorks Corp.

SecureWorks Corp is a cybersecurity provider of technology-driven solutions singularly focused on protecting its customers by outpacing and outmaneuvering the adversary. The company offers its customers the following services; software-as-a-service, or SaaS, solutions, managed solutions, and professional services, including incident response and adversarial services. Its solutions enable organizations to fortify their cyber defenses to prevent security breaches, detect malicious activity in real-time, prioritize and respond to security incidents, and predict emerging threats. The company's products consist of MDR, XDR, Threat Hunting, Log Management, NGAV, EDR, IDPS.

Share on Social Networks: